HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
GLRA2
glycine receptor alpha 2
Chromosome X Β· Xp22.2
NCBI Gene: 2742Ensembl: ENSG00000101958.14HGNC: HGNC:4327UniProt: P23416
27PubMed Papers
21Diseases
0Drugs
10Pathogenic Variants
FUNCTIONAL ROLE
Ion ChannelReceptorTransporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
extracellularly glycine-gated chloride channel activitycellular response to amino acid stimuluscellular response to zinc ioncellular response to ethanolintellectual developmental disorder, X-linked, syndromic, Pilorge typeneurodegenerative diseasegenetic disorderneuroinflammatory disorder
✦AI Summary

GLRA2 encodes the glycine receptor alpha 2 subunit, a component of heteromeric glycine-gated chloride channels that mediate inhibitory neurotransmission 1. As a ligand-gated ion channel, GLRA2 contributes to generating inhibitory postsynaptic currents and down-regulating neuronal excitability 2. Beyond synaptic inhibition, GLRA2 plays critical developmental roles: GlyR Ξ±2 is essential for cortical interneuron migration and progenitor homeostasis, promoting generation of excitatory projection neurons in the embryonic brain 13. The gene also participates in synaptic plasticity and cellular responses to ethanol 41. Pathogenic GLRA2 variants cause early-onset high myopia (eoHM) through impaired photoperception and visual transmission, with myopia transmitted via X-linked inheritance and manifesting as mild cone impairment 56. GLRA2 mutations also associate with neurodevelopmental disorders including autism spectrum disorder, developmental delay, and intellectual disability, often accompanied by microcephaly, language delay, and epilepsy 13. Loss-of-function mutations impair GLRA2 membrane localization and glycine sensitivity, causing deficits in object recognition memory and long-term potentiation 1. GLRA2 was identified as a candidate gene in X-chromosome X association studies 7.

Sources cited
1
GLRA2 contributes to generation of inhibitory postsynaptic currents and down-regulation of neuronal excitability
PMID: 25445488
2
GLRA2 plays a role in cellular responses to ethanol
PMID: 23895467
3
GLRA2 loss-of-function mutations cause autism, impair synaptic plasticity, reduce glycine sensitivity, and affect learning and memory
PMID: 26370147
4
GLRA2 is essential for cortical interneuron migration and progenitor homeostasis; GLRA2 mutations cause neurodevelopmental disorders with microcephaly, language delay, and epilepsy
PMID: 40007572
5
GLRA2 is the third most frequently implicated gene for Mendelian early-onset high myopia with X-linked inheritance
PMID: 40227176
6
GLRA2 variants cause high myopia through altered visual experience by impairing photoperception and visual transmission
PMID: 35396272
7
GLRA2 was identified as a candidate gene in X-chromosome-wide association study for autism spectrum disorder
PMID: 39706197
Disease Associationsβ“˜21
intellectual developmental disorder, X-linked, syndromic, Pilorge typeOpen Targets
0.78Strong
neurodegenerative diseaseOpen Targets
0.34Weak
genetic disorderOpen Targets
0.19Weak
neuroinflammatory disorderOpen Targets
0.14Weak
myopiaOpen Targets
0.12Weak
Blackfan-Diamond anemiaOpen Targets
0.07Suggestive
X-linked severe congenital neutropeniaOpen Targets
0.05Suggestive
Hemoglobin E - beta-thalassemiaOpen Targets
0.04Suggestive
hemoglobin E-beta-thalassemia syndromeOpen Targets
0.04Suggestive
neutropenia, severe congenital, 10, autosomal recessiveOpen Targets
0.04Suggestive
dehydrated hereditary stomatocytosisOpen Targets
0.04Suggestive
X-linked sideroblastic anemia 1Open Targets
0.04Suggestive
inflammatory bowel disease (infantile ulcerative colitis) 31, autosomal recessiveOpen Targets
0.04Suggestive
IRIDA syndromeOpen Targets
0.04Suggestive
neutropenia, severe congenital, 1, autosomal dominantOpen Targets
0.04Suggestive
neutropenia, severe congenital, 2, autosomal dominantOpen Targets
0.04Suggestive
Hemolytic anemia due to red cell pyruvate kinase deficiencyOpen Targets
0.04Suggestive
amegakaryocytic thrombocytopenia, congenital, 2Open Targets
0.04Suggestive
megaloblastic anemia, folate-responsiveOpen Targets
0.04Suggestive
monosomy 7 myelodysplasia and leukemia syndrome 2Open Targets
0.04Suggestive
Intellectual developmental disorder, X-linked, syndromic, Pilorge typeUniProt
Pathogenic Variants10
NM_002063.4(GLRA2):c.887C>T (p.Thr296Met)Pathogenic
not provided|See cases|Intellectual developmental disorder, X-linked, syndromic, Pilorge type
β˜…β˜…β˜†β˜†2024β†’ Residue 296
NM_002063.4(GLRA2):c.392A>G (p.Asp131Gly)Likely pathogenic
Intellectual developmental disorder, X-linked, syndromic, Pilorge type
β˜…β˜†β˜†β˜†2026β†’ Residue 131
NM_002063.4(GLRA2):c.494G>C (p.Arg165Thr)Likely pathogenic
Intellectual developmental disorder, X-linked, syndromic, Pilorge type
β˜…β˜†β˜†β˜†2025β†’ Residue 165
NM_002063.4(GLRA2):c.777C>G (p.Ile259Met)Likely pathogenic
See cases|Intellectual developmental disorder, X-linked, syndromic, Pilorge type
β˜…β˜†β˜†β˜†2022β†’ Residue 259
NM_002063.4(GLRA2):c.407A>G (p.Asn136Ser)Pathogenic
Intellectual developmental disorder, X-linked, syndromic, Pilorge type
β˜†β˜†β˜†β˜†2022β†’ Residue 136
NM_002063.4(GLRA2):c.458G>A (p.Arg153Gln)Pathogenic
Intellectual developmental disorder, X-linked, syndromic, Pilorge type
β˜†β˜†β˜†β˜†2022β†’ Residue 153
NM_002063.4(GLRA2):c.140T>C (p.Phe47Ser)Likely pathogenic
See cases
β˜†β˜†β˜†β˜†2022β†’ Residue 47
NM_002063.4(GLRA2):c.1334G>A (p.Arg445Gln)Likely pathogenic
See cases
β˜†β˜†β˜†β˜†2022β†’ Residue 445
NM_002063.4(GLRA2):c.1199C>T (p.Pro400Leu)Likely pathogenic
See cases
β˜†β˜†β˜†β˜†2022β†’ Residue 400
NM_002063.4(GLRA2):c.1049G>T (p.Arg350Leu)Pathogenic
Intellectual developmental disorder, X-linked, syndromic, Pilorge type
β˜†β˜†β˜†β˜†2011β†’ Residue 350
View on ClinVar β†—
Related Genes
NOVA1Protein interaction85%GRPRProtein interaction71%GLRBShared pathway50%GLRA1Shared pathway47%GLRA3Shared pathway38%GABRA3Shared pathway36%
Tissue Expression6 tissues
Brain
100%
Ovary
10%
Bone Marrow
3%
Liver
1%
Heart
0%
Lung
0%
Gene Interaction Network
Click a node to explore
GLRA2NOVA1GRPRGLRBGLRA1GLRA3GABRA3
PROTEIN STRUCTURE
Preparing viewer…
PDB5BKF Β· 3.60 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.58Moderately Constrained
pLIβ“˜
0.84Intermediate
Observed/Expected LoF0.35 [0.22–0.58]
RankingsWhere GLRA2 stands among ~20K protein-coding genes
  • #12,572of 20,598
    Most Researched27
  • #2,892of 5,498
    Most Pathogenic Variants10
  • #3,825of 17,882
    Most Constrained (LOEUF)0.58 Β· top quartile
Genes detectedGLRA2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 35396272
J Med Genet Β· 2023
1.00
2
Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
PMID: 35685361
Comput Struct Biotechnol J Β· 2022
0.90
3
Chromosome X-wide common variant association study in autism spectrum disorder.
PMID: 39706197
Am J Hum Genet Β· 2025
0.80
4
Clinical and Molecular Landscape of GLRA2 in X-Linked Early-Onset High Myopia.
PMID: 40227176
Invest Ophthalmol Vis Sci Β· 2025
0.70
5
Conserved autism-associated genes tune social feeding behavior in C. elegans.
PMID: 39468047
Nat Commun Β· 2024
0.60